
Immunoglobulin utilization growth 2015-2017, by diagnosis
Between the years 2015 and 2017, immunoglobulin utilization for primary immunodeficiency diseases in selected five developed markets increased almost 11 percent. This statistic illustrates the immunoglobulin utilization growth for the period 2015-2017, by diagnosis.